The following table presents a computation of basic and diluted EPS for the years ended December 31, 2013, 2012 and 2011:


(Dollars in thousands, except per share data)	December 31,
Earnings Per Share	2013		2012			2011
NUMERATORS:
Net income from continuing operations	$	7,935	$	7,560		$	6,684
Less:
Preferred stock dividends		200		880			998
Accretion on preferred stock		0		0			269
Benefit on repurchase and retirement of common stock warrant (1)		0		0			(324	)

Net income from continuing operations available to common shareholders	$	7,735	$	6,680		$	5,741

Net income from discontinued operations	$	0	$	204		$	1,120
Less:
Net income from discontinued operations attributable to noncontrolling interest		0		348			549

Net (loss) income from discontinued operations attributable to controlling interest available to common shareholders	$	0	$	(144	)	$	571

DENOMINATORS:
Weighted average number of common shares outstanding—basic		14,940		16,344			16,991
Effect of potentially dilutive common shares (2)		24		0			0

Weighted average number of common shares outstanding—diluted		14,964		16,344			16,991
EARNINGS (LOSS) PER COMMON SHARE:
Basic attributable to continuing operations	$	0.52	$	0.41		$	0.34
Basic attributable to discontinued operations	$	0	$	(0.01	)	$	0.03
Diluted attributable to continuing operations	$	0.52	$	0.41		$	0.34
Diluted attributable to discontinued operations	$	0	$	(0.01	)	$	0.03
Anti-dilutive options not included in earnings per share calculation		115,837		342,437			214,580
Anti-dilutive warrants not included in earnings per share calculation		0		0			0

(1)

During October 2011, the Company repurchased and retired the common stock warrant issued to the holders of Series A, preferred stock pursuant to the TARP CPP, for $125 thousand. The transaction resulted in a net benefit of $324 thousand which is reported in retained earnings to common shareholders. See Note 20, Shareholders Equity in these Consolidated Financial Statements for further information regarding this transaction.

(2)	Represents the effects of the assumed exercise of warrants, assumed exercise of stock options, vesting of non-participating restricted shares, and vesting of restricted stock units, based on the treasury stock method.